About Reneo Pharmaceuticals
Reneo is a clinical stage pharmaceutical company focused on the development of therapies for patients with genetic mitochondrial diseases. Many of these diseases are associated with deficits in cellular metabolism and energy production. Our goal is to improve daily function and quality of life of patients suffering from these diseases, most specifically, by improving how their mitochondria work, preserving muscle function and preventing muscle injury, weakness and wasting.
We are currently advancing a novel molecule into several diseases. Our experienced team of drug development experts, who have collaborated in many successful programs, are dedicated and passionate about finding effective therapies for these complex rare diseases.
|
|
|
1-10 employees
View all Reneo Pharmaceuticals employees
|
|
Biotechnology Research
|
|
1 858.283.0280
|
|
18575 Jamboree Rd, 275, Irvine, California 92612, US
|
|
2017
|
|
Rare Diseases, Mitochondrial Diseases, Primary Mitochondrial Myopathy
|
Reneo Pharmaceuticals Alternatives
Frequently Asked Questions about Reneo Pharmaceuticals
Gregory J Flesher is the CEO of Reneo Pharmaceuticals.
The decision makers in Reneo Pharmaceuticals are Aneta Ferguson, Chaline Strickland, Gregory J Flesher, etc. Click to Find Reneo Pharmaceuticals decision makers emails.
Reneo Pharmaceuticals Staff Directory
Search Reneo Pharmaceuticals Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.
